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International aid and medical practice in the less-developed
world: Doing it right, what can renal organizations learn? The
delivery of health care in poorer countries is reliant on interna-
tional aid organizations. This article will focus on international
aid and medical practice in the developing world. It will review
the general issues, practices, and problems with international
aid in the medical arena and will then focus on international
aid, kidney detection, and prevention programs. The article will
analyze some of the existing and successful organizations and
their initiatives.
The first part of this article will analyze such aspects as: the
access of existing resources and available aid projects; the estab-
lishment of contact with international aid projects; the access of
funds for the development of the project and, once it is estab-
lished, the management of those funds; the planning of projects;
and the role of research in international aid and medical prac-
tice both as a means of accessing resources and of managing the
project.
The second part of the article will look more specifically at
issues in nephrology and international aid. The focus will be
on current programs in nephrology and the critical appraisal of
some existing programs.
The last part will focus specifically on practical tasks which are
needed when accessing international aid for medical projects.
It will draw on the experiences of various programs and then
outline suggested phases one should consider when establishing
aid projects in order to best implement them.
Kidney groups with intentions to deliver prevention and
management strategies to developing countries need to learn
from the experiences of existing international aid organizations
and chronic kidney disease programs.
It is well accepted that we are unable to afford the
type of care required to manage patients who develop
end-stage renal disease in developing countries. It is also
clear that no nation will escape the burden, unless its gov-
ernment and health care leaders decide to act. The preva-
lence of all chronic conditions is growing inexorably and
is seriously challenging the capacity and will of govern-
ments to provide coordinated systems of care [1]. Also,
the burden of these conditions falls most heavily on the
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poor. One-dimensional solutions will not solve this com-
plex problem. Health status and quality of life will not be
improved solely by medication and technical advances,
and thus health care systems will have to move away from
a model of “find it and fix it.” In addition, these solutions
cannot be delayed, and the sooner governments invest
in care for chronic conditions, the better. This realiza-
tion has resulted in a number of initiatives by individuals,
nongovernmental organizations (NGOs), and renal soci-
eties to establish kidney disease renoprotection programs
(KDRP). However, it should be realized that establish-
ing a KDRP relies on the ability to acquire skills and
access resources. So, we have to balance this enthusiasm
with practical reality, which recognizes that the majority
of countries most needing prevention programs are also
those in which prevention programs are the most difficult
to establish.
INTERNATIONAL AID AND MEDICAL
PRACTICE IN THE DEVELOPING WORLD
Existing international aid organizations—aims and
projects
It is important to critically appraise some international
aid organizations (IAOs) in our endeavors to establish
our own chronic kidney disease programs.
The World Health Organization (WHO) was estab-
lished in 1948. It aims to achieve health care for all
by communicating evidence-based policy; managing in-
formation and stimulating research; developing change
through technical and policy support; building sustain-
able capacity; and negotiating and sustaining national and
global partnerships. It wishes to set up, validate, monitor,
and pursue proper implementation of norms and stan-
dards, tools, and guidelines for disease control; risk re-
duction; health care management; and service delivery
[2]. These ideals are those of most IAOs.
The Global Forum for Health Research (GFHR),
based in Geneva, Switzerland, works closely with the
WHO but has a stronger focus on the developing world.
Its central objectives include “correcting the 10/90 gap”
by promoting research to improve the health of poor
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people. The GFRH runs an annual meeting, which fo-
cuses on helping to develop priority-setting methodolo-
gies by supporting networks in priority health research
areas. Thus, the GFRH plans to achieve its goals through
established support networks [3].
The Initiative for Cardiovascular Health Research in
developing Countries (IC Health) is another NGO that
shares similar interests. IC Health, however, works closer
to the “coal face” than the previous 2 NGOs. It prior-
itizes resource-sensitive research and research on sus-
tainable models of prevention to address the growing
burden of cardiovascular diseases in developing coun-
tries. It also prioritizes prevention through primary health
care in these settings. IC Health acknowledges that even
though methods of prevention are known, for exam-
ple, use of angiotensin-converting enzyme inhibitors and
management of risk factors, they still need to be deliv-
ered in the challenging health care conditions of devel-
oping countries. Its program often has a surveillance and
intervention component. IC Health also recognizes the
importance of capacity and skills development to man-
age these programs. It believes these skills will ultimately
lead to institutional strengthening and sustainability. IC
Health also recognizes that epidemiology, biostatistics,
and data management skills are critical components to
developing skills and capacity [4]. These latter aspects
of capacity-building and economics are critical in win-
ning support from developing country governments and
for attracting funding grants from international funding
groups.
Me´decins Sans Frontie`res (MSF), established in 1970,
is an exceptional medical care organization that pro-
vided support to vulnerable populations for decades. It
is a grass roots organization working on approximately
400 projects in 80 countries around the globe [5]. The
MSF’s focused activities include mainly emergency in-
terventions providing assistance after natural disasters,
epidemics, and armed conflicts. However, more recently
the MSF has established epidemiologic programs for
resource-poor populations that have neither the means
nor technical knowledge [6]. The latter programs and
their practical nature are of particular interest to nephrol-
ogy groups with similar aspirations.
Having reviewed these IAOs, it is important to criti-
cally appraise their ability to achieve their goals and carry
out their activities.
Analyses of IAOs
Although IAOs express wonderful ideals, it is not al-
ways possible to achieve them. Einterz makes us realize
that we need to recognize a few important facts, includ-
ing the reality that there is no substitute for formal health
structures [7]. Although MSF, WHO, IC Health, and the
GFHR aim to complement formal health sectors, there
remains an ongoing moral dilemma in providing health
Table 1. Difficulties for people and organizations trying to establish
prevention programs
Making intellectual resources available to the people who most need
them.
The ability for people to access existing resources for aid projects.
Establishing contact with international aid projects.
Accessing funds for the development of the project and, once it is
established, the management of these funds.
Planning and then sustaining the projects.
Evaluating the role of research in international aid and medical
practice both as a means of accessing resources and of managing
the project.
care to vulnerable populations. This includes the devel-
opment of dependence on external assistance, which can
minimize a government’s responsibility to deliver health
care, and the projects can be manipulated by existing gov-
ernments or the real problems can be masked [7]. Real
problems, therefore, exist for an IAO (Table 1). There
is a need to convert action plans and intentions to real
success, and there is also a need to reduce the plausible
reasons explaining failure (e.g., inflation, no stability, lack
of political will, time, and logistics, mismanagement, and
corruption and theft by managers) [7].
The WHO is really only accessible to individuals
through direct government application, making it largely
inaccessible to the average aid program. Its focus is more
on the whole population at risk rather than the individual.
On a positive side, the WHO has a strong emphasis on pri-
mary prevention rather than secondary prevention and
treatment of chronic diseases. It is also very well funded,
but this funding is not easily accessible.
The GFHR and IC Health have an active positive
history of being involved in scientific, research-based
projects. The emphasis on science does have a nega-
tive aspect, because it requires certain baseline skills. IC
Health developed from the establishment of partnerships
with international organizations like the World Bank and
WHO. It has a strong focus in the primary care setting and
emphasizes qualitative as well as quantitative research.
GFHR is focused on core issues and has a long-term out-
look and commitment of involvement in the developing
world sector. Negatives include the problem of available
skills and funding shortages for projects, which impacts
sustainability. It is also difficult for appropriate commu-
nities to access these funds. Admittance thus depends
on initial contacts and skills to write funding proposals.
Grant funding requires significant abilities and resources,
especially time, and in the developing world, clinicians are
overburdened with clinical responsibilities.
MSF is one of those grass-root organizations from
which we have much to learn. It has a very strong cul-
ture of volunteering [5]. The volunteers spend extended
time in communities, and they transfer skills while they
are conducting their programs. Programs are also de-
veloped with local community and local NGO input.
MSF emphasizes the facet of evaluating local problems
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Table 2. Important components needed to establish chronic kidney disease programs.
Support from government, local community organizations (NGOs), health workers, and patients.
Securing some form of bridging assistance from an IAO, whether financial or other, such as equipment, human resources, or technical skills.
The establishment of a productive interaction between patients and the health practice team.
The establishment of an organized, integrated program as compared with the usual standard “find it, fix it” model of care existing in most
countries. Organized care has shown better outcomes compared with standard care programs.
A strong primary health care focus with the PHC nurse being critical, especially in developing and poorly developed countries (Yawn, 2000).
Abbreviations are: NGOs, nongovernmental organizations; IAO, international aid organization; PHC, primary health care.
in the country together with local NGOs or government
structures. However, MSF requires significant funding to
support its volunteers, which is prohibitive for many aid
organizations. MSF has significant funding and organiza-
tional skills, which have developed because of its good
track record. It must be said that MSF has only recently
started chronic disease programs, and sustainability with
chronic illness management is critical.
Ideal components for IAO programs for the management
of chronic disease illnesses
There are important components to establishing a
chronic disease illness program (Table 2) [8]. The WHO
recognizes the difficulty in achieving ideal circumstances,
and therefore advises those in the developing world to
follow a more practical approach. This approach should
be modified according to one’s capacity [9]. So if the
only method available is lifestyle modification, then this
is where one should start and not be discouraged to start
from there. Therefore, the aim is to develop basic sentinel
surveillance and treatment sites and then to add on to the
established program.
INTERNATIONAL AID AND THE
NEPHROLOGIST
The nephrologist needs to learn from the general prin-
ciples of established aid organizations. The physician in
the developing world has a few options to consider before
starting a program. First, a KDRP could be established
on its own, with primary focus being the kidney as the
organ to treat. The second option could be for the kid-
ney to fall under the gambit of all chronic illnesses, while
recognizing that managing the key chronic illnesses’ risk
factors, such as hypertension and diabetes, will have the
greatest impact on reducing the progression of kidney dis-
ease. However, it can be said that even if one starts more
specifically maintaining one’s own “organ identity,” it will
be unlikely and shortsighted should one want to progress
further to ignore all other cardiovascular and infectious
disease known to cause chronic disease.
International renal aid organizations
The International Society of Nephrology (ISN) is an
international renal organization that has both the focus
and the capacity to work in poorer countries. Through the
Commission for the Global Advancement of Nephrology
(COMGAN), a great deal of networking has taken place.
It is through this networking that projects are developed,
grant funding is sourced, and global networks develop
to establish prevention strategies worldwide. Significant
work has also taken place through existing kidney foun-
dations and pharmaceutical funding. An example of this
would be the Prevention of Renal and Vascular End-stage
Disease program sponsored by the Dutch Kidney Foun-
dation [10]. There are a few KDRPs around the world,
and the ISN has managed to establish a fairly loose net-
work of these groups and has also published, more re-
cently, the findings of these kidney disease screening and
prevention initiatives [11].
Establishing KDRPs
Having covered the practices and functioning of in-
ternational aid, the focus has moved to specific practical
tasks and processes, which one should consider when ac-
cessing international aid and starting a program.
Wendy Hoy in Australia is probably the person with
the most experience for establishing kidney and cardio-
vascular protection programs. Her team has helped de-
velop programs in Australian Aboriginal communities
and other countries, including India, Nigeria, and South
Africa. The key to this development is to engage com-
munity interest in chronic illness management and pre-
vention strategies, to help assess needs in the community,
and to develop an agreement with the local community
or health authority [12]. Once these basic requirements
have been met, then one can go on to help local staff im-
plement the program and strive to ensure sustainability
by providing mechanisms or skills to evaluate processes
and outcomes that have been established. These are some
of the fundamental necessities required to develop sus-
tainable and accepted chronic kidney programs.
THE MODEL FOR PREVENTION PROGRAMS
Focus on existing kidney detection
and prevention strategies
When establishing a CKD program, the options include
either screening an entire population, as in the Dutch Pre-
vention of Renal and Vascular End-stage Disease and
Australian Aboriginal studies, or detecting a cohort of
people at the highest risk of kidney disease [10, 13, 14]. It
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Where to start
A prevention or
remission
program?
ESRD
CKD 4
Preparing people for
renal replacement
therapy (ESRD)
Prevent progression
KDRP programs or remission clinics
Detection of initiator/injury
Protein leakage, proteinuria, reduction of GFR
Locate people at risk for CKD
Diabetes, hypertension, elderly, HIV
Screening the general population or focus on the high-risk
population
Fig. 1. Doing it right.
is clear that the former approach is more costly and less
likely to be achieved in the developing world. However,
one has to make this judgment based on local conditions
and resources (Fig. 1). A few existing models are evalu-
ated below.
Kidney Help Trust Rural Project in India
In India, Muthu K. Mani developed a primary care
chronic disease program with a focus on proteinuria, hy-
pertension, diabetes, and other renal diseases [15]. It was
run by local community participants (health workers) and
included a screening and treatment component. The suc-
cesses of this very exciting project were its simplicity; as
stated by Dr. Mani himself, “We keep it simple.” It was
also a cheap mass screening campaign, including 25,000
people, and this was an early detection program. It was
primary health care nurse–driven, and these nurses were
used to detect disease and give basic treatment under su-
pervision. The problems included no available long-term
quantitative data, and therefore Dr. Mani was unable to
evaluate the impact of his intervention. He also noted
that only 8% of the participants took ongoing treatment
and that nurses were only able to visit homes every 18
months.
The Bolivian Renal Disease Project
This was a collaborative project between Drs. Plata
and Remuzzi, under the support of the Bergamo Insti-
tute and ISN-COMGAN. It was an educational cam-
paign and population-based mass screening for urinary
disease in healthy patients [16]. About 14,000 patients
were screened, and urinary abnormalities were detected
in over 4000. These people were referred to local health
centers and were to be followed up over the next 3 years.
The successes of this project outlined the basis for start-
ing all such programs; that is, gaining a good understand-
ing of local problems with a simple and cheap test. This
study helped define the incidence of asymptomatic renal
diseases in an unselected population. It showed that it
is possible to screen a large population at relatively low
cost (similar to Mani’s project in India), which provides
the framework for further action that may help in the
prevention and timely diagnosis of renal diseases. It was
also run in both an urban and rural setting.
The follow-up phase requires sustainability. Follow-up
has proven to be a difficult task in most developing coun-
try projects, especially when the projects are NGO or
donor-funding driven and not strongly supported by the
government.
Australian Chronic Disease Outreach Program
Wendy Hoy’s Australian Outreach program remains
an ideal template on which to develop a prevention pro-
gram [12, 13]. It has both a screening and treatment pro-
gram. It started on the Tiwi Islands and has since extended
to other Aboriginal areas in Australia. It involves mass-
community screening, with the aim of detecting high-risk
groups and then providing treatment. The communities
range from a few hundred to a couple of thousand. The
Kidney Disease Research Program has also helped to es-
tablish programs elsewhere (see below). The program has
significantly reduced morbidity and mortality of kidney
and cardiovascular disease [13]. It has influenced national
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Assess CKD burden and
community knowledge
Expert international and local
support and
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Fig. 2. Kidney disease renoprotection
programs. Where to start?
protocols, becoming a government lobby group and gal-
vanizing NGOs in Australia. A big factor in the program’s
success is the excellent existing skills and funding of this
organization. However, both of these have been built on
the successes of the organization. These Aboriginal com-
munities also exist in a wealthy, developed country. The
programs still rely on community support, and this has
not always been forthcoming from health authorities in
some communities. This appears to be changing because
of the program’s success. However, despite successes, it
is still slow to change and influences day-to-day practice
throughout Australia, and the Aboriginal people remain
a marginalized minority relying on “paternalism” from
the majority white Australians.
The Chronic Disease Outreach Primary Prevention
Program in South Africa
The development of the South African KDRP is an
ideal example of using international aid organizations.
The program was developed with the support of the Aus-
tralian Kidney Disease Research Program and adapted
to South African conditions. The South African program
takes place in Soweto, a melting pot of people in tran-
sition from a healthy traditional lifestyle to a western-
ized one. This has made them at high risk for chronic
diseases such as diabetes, hypertension, and kidney dis-
ease. Against a known background of poor blood pres-
sure and glucose control, the program was implemented
in 16 primary care clinics in Soweto and nearby regional
clinics [17]. A tertiary hospital served as the focal point for
data collection and program management. The program
was an integrated chronic illness program focusing on
detecting high-risk patients and controlling their hyper-
tension, diabetes, and risk factors [14]. The program was
developed around an integrated chronic illness model,
which includes simplifying targets for blood pressure, glu-
cose, and proteinuria control, providing ongoing educa-
tion and support with patient management, as well as
regularly evaluating the achievement of set clinical tar-
gets. The program had a qualitative component that
focused on the primary health care team. The first
phase had a surveillance component, providing base-
line data, but it also achieved success with blood pres-
sure control and limited success with diabetes control
and protein reduction. In phase 2 of the program, the
Australian KDRP sent nurse coordinators to train local
coordinators. The South African program continues to
get strong support from Australia, including assistance
with data evaluation and skills development. The pro-
gram is strongly supported by local health structures and
authorities. The program has provided a better under-
standing of renal disease and cardiovascular risk, pos-
itive, short-term treatment outcomes, and a model for
international medical aid. It is important to say that
the assistance was set up through the ISN COMGAN
network. After 5 years, it demonstrates stamina and
sustainability.
CONCLUSION—DOING IT RIGHT!
This article has attempted to demonstrate that it is pos-
sible to establish chronic kidney disease detection and
prevention programs in the developing world. Some crit-
ical components are needed to achieve this (Fig. 2), but
it is possible, as is demonstrated by the successful pro-
grams that currently exist. Strong links with international
medical organizations are essential. It is clear that certain
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fundamentals are required when managing chronic dis-
eases in less-developed countries: the establishment of
an informed and proactive health team as well as strong
patient and community partnerships. These components
remain as important as adequate funding and the exis-
tence of certain basic research and health management
skills. One has to focus not only on the technical and sci-
entific aspects but also on supporting or caring for staff.
The paradox being that continuing care delivered by a
well-functioning team is the basis on which control of
chronic disease must rest [1].
Reprint requests to Dr. Ivor Katz, P.O. Box 92188, Norwood, Johan-
nesburg, 2117, South Africa.
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